MAT documentation has specific federal requirements.
Buprenorphine, methadone, naltrexone, each has regulatory documentation standards. A general scribe doesn't know the difference.
MAT note formats, toxicology-aware timelines, and documentation designed to hold up in a regulatory review.
Buprenorphine, methadone, naltrexone, each has regulatory documentation standards. A general scribe doesn't know the difference.
UDS results, timing, and clinical interpretation belong in the assessment, not in a separate lab order.
Relapse events, medication changes, crisis episodes: what happened six weeks ago shapes the clinical decision today.
Buprenorphine initiation, maintenance, taper, and crisis templates, written to satisfy the documentation requirements for prescribing under standard DEA registration.
UDS results, medication-assisted levels, treatment response documented across every visit. Know what changed and when.
Tag your active MAT panel. Filter by medication, stage, or risk level. See who hasn't checked in this week.
The MAT template was accurate on day one. That doesn't happen with general scribes, you spend six weeks training them on terminology they never fully get.
Unlimited notes, MAT templates, AI patient timeline, custom cohort tags, and all compliance features. Start free, no credit card required.
We run a mock session live, draft the note, and walk through what the downstream claim would look like. No slides. No sales deck.